Response to PARP inhibitors in patients with breast cancer metastatic to the central nervous system

被引:0
|
作者
Lee, Seoho
Bansal, Rani
Hughes, Melissa E.
Van Swearingen, Amanda E.
Moore, Heather N.
Kamson, David O.
Sahebjam, Solmaz
Kirkner, Greg
Gorfinkel, Anna
Sammons, Sarah
Lin, Nancy U.
Anders, Carey
Santa-Maria, Cesar A.
机构
关键词
D O I
10.1158/1538-7445.AM2024-6472
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
6472
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Risk factors for central nervous system metastasis in patients with metastatic breast cancer
    Sezgin, Canfeza
    Gokmen, Erhan
    Esassolak, Mustafa
    Ozdemir, Necmettin
    Goker, Erdem
    MEDICAL ONCOLOGY, 2007, 24 (02) : 155 - 161
  • [2] Risk factors for central nervous system metastasis in patients with metastatic breast cancer
    Canfeza Sezgin
    Erhan Gokmen
    Mustafa Esassolak
    Necmettin Ozdemir
    Erdem Goker
    Medical Oncology, 2007, 24 : 155 - 161
  • [3] The Role of PARP Inhibitors in Patients with Primary Malignant Central Nervous System Tumors
    Gueble, Susan E.
    Vasquez, Juan C.
    Bindra, Ranjit S.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2022, 23 (11) : 1566 - 1589
  • [4] The Role of PARP Inhibitors in Patients with Primary Malignant Central Nervous System Tumors
    Susan E. Gueble
    Juan C. Vasquez
    Ranjit S. Bindra
    Current Treatment Options in Oncology, 2022, 23 : 1566 - 1589
  • [5] Associations with response to Poly(ADP-ribose) Polymerase (PARP) inhibitors in patients with metastatic breast cancer
    Desnoyers, A.
    Nadler, M.
    Wilson, B. E.
    Stajer, S.
    Amir, E.
    NPJ BREAST CANCER, 2022, 8 (01)
  • [6] Metastatic breast cancer subtypes and central nervous system metastases
    Aversa, C.
    Rossi, V.
    Geuna, E.
    Martinello, R.
    Milani, A.
    Redana, S.
    Valabrega, G.
    Aglietta, M.
    Montemurro, F.
    BREAST, 2014, 23 (05): : 623 - 628
  • [7] Biologic Profile of Metastatic Breast Cancer to the Central Nervous System
    Mingrino, Jennifer
    Punsoni, Michael
    Wang, Yihong
    LABORATORY INVESTIGATION, 2024, 104 (03) : S1758 - S1760
  • [8] Central nervous system metastases in women with metastatic breast cancer
    Hawkins, M
    Lalondrelle, S
    Neal, AJ
    BRITISH JOURNAL OF CANCER, 2004, 91 : S27 - S27
  • [9] Associations with response to Poly(ADP-ribose) Polymerase (PARP) inhibitors in patients with metastatic breast cancer
    A. Desnoyers
    M. Nadler
    B. E. Wilson
    S. Stajer
    E. Amir
    npj Breast Cancer, 8
  • [10] Therapeutic potential of PARP inhibitors for metastatic breast cancer
    Irshad, Sheeba
    Ashworth, Alan
    Tutt, Andrew
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (08) : 1243 - 1251